Ceva Animal Health has extended the licence for Eprecis injection, its zero-milk withdrawal targeted wormer, which is now be available for use in sheep and goats as well as cattle.
Containing eprinomectin as its active ingredient, Eprecis injection is an easy to administer endectocide with broad spectrum activity against gastrointestinal nematodes in sheep and goats.
After Eprecis injection, Haemonchus contortus in the abomasum in goats were reduced by 97.8 percent and Trichostrongylus colubriformis in the small intestine were reduced by 98.7 percent.
In lactating dairy ewes, Eprecis injection was found to be 99 percent effective against gastrointestinal nematodes and was associated with an increased milk yield of 8 percent.
Moreover, the bioavailability of eprinomectin after one Eprecis injection in goats is larger than that reported for eprinomectin pour on (section 5.2).
Eprecis injection was found to be four times more efficacious than eprinomectin pour-on across four dairy goat farms (Couasnon, 2019; translated summary from Ceva internal technical book).
In sheep, the efficacy of Eprecis injection against gastrointestinal nematodes in sheep is 99.6 percent versus 86.1 percent for a pour-on formulation.
Furthermore, Eprecis injection is associated with higher plasma levels of eprinomectin and has a higher efficacy compared to eprinomectin pour-on in dairy ewes naturally infected with gastrointestinal nematodes. This is also achieved using five times less active than a pour-on formulation.
Eprecis injection is easily administered subcutaneously and there is no need to part the fleece or coat along the animal’s back.
It has excellent syringeability (poster P04-004-079, 29th WBC) and a low dose volume (0.1ml/10kg) allowing accurate dosing of animals.
Harry Walby, ruminant veterinary advisor at Ceva Animal Health, comments: “Eprecis injection is a highly effective broad-spectrum wormer that is now available in sheep and goats, as well as cattle.
“The injectable formulation not only allows accurate dosing, but there is no subclinical dose transfer between animals.”
Eprecis injection is available in 100ml and 250ml CLAS vials, which are 33 percent better for the environment than glass vials (Jacquet et al., 2016), are shock resistant and ergonomically shaped for ease of handling (CLAS vials reference book, Section 5.2).
For further information on Eprecis please contact your local Ceva Animal Health territory manager or email Ceva UK.
